Related Experiment Video

Updated: Apr 29, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

17.8K

Managing the skin toxicities from new melanoma drugs

John C Mavropoulos1, Timothy S Wang

  • 1Department of Dermatology, Johns Hopkins Outpatient Center, Johns Hopkins University, 601 N. Caroline Street, Baltimore, MD, 21287, USA, drjohnmavpub@gmail.com.

Current Treatment Options in Oncology
|May 29, 2014
PubMed

Insights

Patients receiving advanced melanoma treatments like ipilimumab or targeted inhibitors can develop skin toxicities (DAEs). Prompt recognition and management of these dermatologic adverse events are crucial for effective cancer therapy.

Area of Science:

  • Oncology
  • Dermatology

Background:

  • Advanced cutaneous melanoma treatments, including ipilimumab and RAF-MEK-ERK pathway inhibitors (vemurafenib, dabrafenib, trametinib), frequently cause dermatologic adverse events (DAEs).
  • While typically not life-threatening, DAEs can significantly impact treatment adherence and outcomes if not managed promptly.

Purpose of the Study:

  • To highlight the importance of early recognition and management of DAEs in patients undergoing advanced melanoma therapy.
  • To emphasize the need for physicians to be vigilant for both known and novel DAEs associated with new melanoma drugs.

Main Methods:

  • Review of clinical observations and therapeutic strategies for managing DAEs in melanoma patients.
  • Emphasis on early diagnosis, dermatological consultation, and biopsy of suspicious lesions.

Main Results:

  • DAEs are common but manageable with various therapeutic options.
  • Timely intervention improves patient care and maintains the efficacy of oncologic treatments.

Conclusions:

  • Early identification and proactive management of DAEs are essential for optimizing patient care and treatment effectiveness in advanced cutaneous melanoma.
  • A low threshold for biopsy and dermatologist consultation is recommended for managing concerning skin findings.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K
A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.3K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.3K
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
3.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
206